Abstract
IntroductionLate presentation for HIV care is a well-described issue for the success of ART outcomes and the cause of higher morbidity, mortality and further transmission. Monitoring the level of late presentation and understanding the factors associated with it would help to tailor screening and information strategies for better efficiency.We performed a retrospective cohort study in Kinshasa, the capital of the DRC. The studied population included HIV-positive adults newly enrolled in HIV care between January 2006 and June 2020 at 25 HIV urban care facilities. Patient information collected at presentation for HIV care included age, sex, WHO clinical stage and screening context. We used 2 definitions of late presentation: the WHO definition of advanced HIV disease (WHO stage 3/4 or CD4 cell count < 200 cells/mm3) and a more inclusive definition (WHO stage 3/4 or CD4 cell count < 350 cells/mm3).ResultsA total of 10,137 HIV-infected individuals were included in the analysis. The median age was 40 years; 68% were female. A total of 45.9% or 47.5% of the patients were late presenters, depending on the definition used. The percentage of patients with late presentation (defined as WHO stage 3/4 or CD4 cell count < 350 cells/mm3) decreased during recent years, from 70.7% in 2013 to 46.5% in 2017 and 23.4% in 2020. Age was associated with a significantly higher risk of LP (p < 0.0001). We did not observe any impact of sex.ConclusionsThe frequency of late presentation for care is decreasing in Kinshasa, DRC. Efforts have to be continued. In particular, the issue of late diagnosis in older individuals should be addressed.
Highlights
Late presentation for human immunodeficiency virus (HIV) care is a well-described issue for the success of Antiretroviral therapy (ART) outcomes and the cause of higher morbidity, mortality and further transmission
A total of 10,137 HIV-infected individuals were included in the analysis
The frequency of late presentation for care is decreasing in Kinshasa, Democratic Republic of Congo (DRC)
Summary
Late presentation for HIV care is a well-described issue for the success of ART outcomes and the cause of higher morbidity, mortality and further transmission. The WHO guidelines recommended that ART should be initiated in everyone living with HIV with any CD4 cell count [3]. The implementation of the WHO and national guidelines led to a significant decrease in time from diagnosis to treatment initiation, as shown in multiple studies in Sub-Saharan Africa [5,6,7].
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have